EN
A brain tumour frightens people not only by the word “brain” but by the sense that the person themselves is at stake: speech, movement, memory. And that is exactly why decisions here must not be taken in haste. German neuro-oncology answers that fear with precision: first establish what kind of tumour it is and where it lies to within a millimetre, and only then choose how to approach it, disturbing as little healthy tissue as possible.
How people usually arrive
The trigger varies — persistent headaches, a seizure, changes in vision or speech — and the tumour is usually found on MRI. The person already has the images and an alarming report, but most often no answers to the main questions: what kind of tumour this is by nature, benign or malignant, and whether it can be approached safely. Those cannot be answered from a single scan.
How the diagnosis is confirmed in Germany
The main method is magnetic resonance imaging, including special sequences that show not only the shape of the tumour but how it relates to important areas of the brain and to the nerve pathways. Where needed, positron emission tomography (PET) is added: it shows the activity of the tissue and helps distinguish the most aggressive parts of the tumour from the quieter ones.
But a scan shows where the tumour is and how it behaves, not what it is at cell level. Only examination of the tissue gives that answer, so in many cases a biopsy is taken — sometimes with stereotactic technique, in which equipment calculates the path and a sample is taken from a deep lesion through a small access. The tissue is examined by a pathologist, and today molecular analysis is always added: brain tumours have genetic features that determine both the exact diagnosis and the choice of drug therapy.
Which approaches are used
Where the tumour is reachable, surgery plays the key role. Its task is to remove as much of the tumour as possible without touching functionally important areas. That is what the technology of German hospitals serves: neuronavigation, which guides the surgeon along a map of the brain built in advance, and operations during which function is monitored — sometimes the patient is woken for part of the operation to confirm that speech and movement are intact. That is what gentle surgery means when it comes to the brain.
Where an operation is impossible or not enough, radiotherapy is used, including high-precision forms that deliver the dose to the target while sparing the surrounding tissue. In malignant tumours, drug therapy is added: chemotherapy and, according to the molecular analysis, targeted drugs. Which combination to use and in what order is decided by a neuro-oncology board, where neurosurgeon, oncologist, radiation oncologist, neurologist and pathologist look at the case together.
Importantly, treatment follows approved protocols rather than one doctor’s personal preference. The protocol sets a justified frame within which the board chooses a solution for the particular tumour and its location.
When a second opinion makes sense
With a brain tumour a second opinion is particularly apt before deciding on an operation. A German specialist reviews the images and, if there is tissue, the pathologist’s report, and says whether they agree with the diagnosis and the proposed approach, and whether the tumour can realistically be reached in a gentler way. Sometimes that changes the plan — and with the brain the value of the right plan is especially high.
This material is for information only and does not replace a consultation with a doctor. Whether treatment is possible, what it will involve and what it will achieve can be determined only after an examination at the clinic in person.